Fundraising FoxDevelo
Los Angeles, US · Founded 2022 · Delaware corporation · 8 known investors
Find your way into Develo
Develo builds pediatric practice management software that goes beyond a traditional EMR, handling scheduling, clinical charting, billing, and family engagement for independent pediatric practices. Its FHIR-native platform uses a family-centered data architecture to support adolescent confidentiality and integrations with text, e-fax, e-prescribe, e-lab, payer, and vaccine registry systems.
Also known as Develo, Inc.
Founders & leadership
Develo was founded in 2022 by Han Ke and Aaron Sin, MD.
Board
Investors · 8
How we know: Blueprint Equity's portfolio page · press coverage · research · techstartups.com · Not right? Tell us
How we know: Z21 Ventures's portfolio page · press coverage · research · techstartups.com · Not right? Tell us
How we know: press coverage · research · techstartups.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$12.5M disclosed across 2 of 5 rounds · 2023–2026
- Undisclosed amountGrowth RoundMay 2026
Blueprint Equity (lead), Bienville Capital, Villain Capital, Z21 Ventures
Source ↗
▶$10MraisedFeb 2026 · 5 investors · Other TechnologyRule 506(b)
- Han KeExecutive Officer, Director, Promoter
- Aaron Tsz-Kit SinExecutive Officer, Director, Promoter
- Sheldon LewisDirector
- Offering amount
- $14M
- Amount sold
- $10M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.5MraisedOct 2023 · 1 investors · Other TechnologyRule 506(b)
- Aaron Tsz-Kit SinExecutive Officer, Director, Promoter
- Han KeExecutive Officer, Director, Promoter
- Offering amount
- $4M
- Amount sold
- $2.5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Develo, Inc. is a Los Angeles-based health software company that develops an end-to-end electronic medical record and practice-management platform built specifically for independent pediatric practices. The product unifies scheduling, charting, intake, billing and family engagement in a single system, replacing the combination of a traditional clinical EMR, a standalone intake tool and a separate billing system that many pediatric clinics operate today. The company positions the product as an AI-native operating system for pediatrics rather than an AI feature layered onto an existing adult-medicine EMR.
AI capabilities described by the company and its investors include an embedded AI scribe, automated pediatric charge capture, and chart and practice reporting intelligence, spanning clinical, billing and family-engagement workflows. The platform is FHIR-native and, according to a Medplum case study cited in a company profile, is built on Medplum and self-hosted in Develo's own AWS environment with multi-tenant separation for each pediatric practice.
Founding story
Develo was founded in 2022 by Aaron Sin, MD, who serves as CEO, and Han Ke, who serves as CTO, to address the fragmented tooling used by pediatric practices.
Business model
Develo sells software to independent pediatric practices, consolidating clinical records, billing and family communication into one platform in place of multiple point tools.
Traction
The company says its software is used by hundreds of pediatric providers across more than two dozen states, and reports that practices on the platform see an average net revenue increase of roughly 20% and about 10 hours saved per user per week.
Latest developments
In May 2026 Develo announced a $14 million round led by Blueprint Equity with participation from Villain Capital, Z21 Ventures and Bienville Capital, plus healthcare technology angels including CentralReach CEO Chris Sullens, Community CareLink executive chair Chris Barton and former Allscripts CEO Paul Black. Proceeds are earmarked for research and development and for expanding customer success operations.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Develo targets a pediatric care market that touches more than one-third of Americans and accounts for over 450 million visits annually, a segment described as still running heavily on legacy healthcare software. It differentiates from AI scribe and workflow-automation vendors that layer onto incumbent systems by rebuilding the underlying operating layer, and from legacy EMR vendors through a family-centered data architecture and integrated AI features.
The platform is purpose-built for pediatric care rather than adapted from software designed for adult medicine, is FHIR-native, and embeds AI in documentation and charge capture rather than offering AI bolt-ons to legacy systems. The company markets a family-centered data architecture as a further point of difference.
Technology
FHIR-native EMR and practice-management platform built on Medplum, self-hosted in Develo's own AWS environment with multi-tenant separation per practice. Features include an embedded AI scribe, automated pediatric charge capture, and chart and practice reporting intelligence.
Go-to-market
Direct sales to independent pediatric practices, with post-funding plans to expand research and development and grow customer success operations.
Independent pediatric practices and the pediatricians and administrative staff who work in them.
Geography
Headquartered in Los Angeles, California, with providers using the platform in more than two dozen U.S. states.
History
Founded in 2022 in Los Angeles, Develo raised earlier-stage capital including a 2023 seed round, with Z21 Ventures and Fractal Software named among prior investors. In May 2026 the company announced a $14 million Series A led by Blueprint Equity, first reported as an Axios Pro exclusive.
Compiled by commissioned research from 2 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlapCompanies competing with Develo for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 1
launches, deals, and filingsDevelo announced a $14 million round led by Blueprint Equity, with participation from Villain Capital, Z21 Ventures and Bienville Capital, and angel investors including CentralReach CEO Chris Sullens, Community CareLink executive chair Chris Barton and former Allscripts CEO Paul Black. Funds are to expand R&D and customer success operations.
$14M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 2
primary sources listed
- Develo raises $14M to replace outdated pediatric EMRs with AI-native operating system - Tech Startupstechstartups.com · web
2 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Develo do?
- Develo builds an AI-native, pediatrics-specific operating system combining EMR, billing and family engagement for independent practices.
- Who founded Develo?
- Develo was founded by Han Ke, Aaron Sin, MD in 2022.
- Who are Develo's investors?
- Develo's investors include Blueprint Equity, Fractal Software, Z21 Ventures, Bienville Capital.
- How much funding has Develo raised?
- Develo has disclosed $12.5M raised across 2 of its 5 known rounds.
- Where is Develo headquartered?
- Develo is headquartered in Los Angeles, US.